Shawn David Roman - 06 Nov 2024 Form 3 Insider Report for Apyx Medical Corp (APYX)

Role
Chief Operating Officer
Signature
/s/ Shawn Roman
Issuer symbol
APYX
Transactions as of
06 Nov 2024
Net transactions value
$0
Form type
3
Filing time
17 Jan 2025, 16:05:19 UTC
Next filing
17 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 12,000 $1.80 Direct F1
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 15,000 $3.23 Direct F2
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 50,000 $7.91 Direct F3
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 50,000 $8.18 Direct F4
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 25,000 $9.29 Direct F5
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 50,000 $10.96 Direct F6
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 50,000 $2.50 Direct F7
holding APYX Employee Stock Option (right to buy) 06 Nov 2024 Common Stock 50,000 $2.42 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person was granted a stock option on 03/16/2016, which vests in four equal annual instalments on each of the first, second, third, and fourth anniversaries of the grant date.
F2 Reporting Person was granted a stock option on 05/01/2017, which vests in four equal annual instalments on each of the first, second, third, and fourth anniversaries of the grant date.
F3 Reporting Person was granted a stock option on 01/09/2019, which vests in three equal annual instalments on each of the first, second, and third anniversaries of the grant date.
F4 Reporting Person was granted a stock option on 01/15/2020, which vests in three equal annual instalments on each of the first, second, and third anniversaries of the grant date.
F5 Reporting Person was granted a stock option on 01/29/2021, which vests in three equal annual instalments on each of the first, second, and third anniversaries of the grant date.
F6 Reporting Person was granted a stock option on 01/19/2022, which vests in three equal annual instalments on each of the first, second, and third anniversaries of the grant date.
F7 Reporting Person was granted a stock option on 01/11/2023, which vests in three equal annual instalments on each of the first, second, and third anniversaries of the grant date.
F8 Reporting Person was granted a stock option on 01/10/2024, which vests in three equal annual instalments on each of the first, second, and third anniversaries of the grant date.